Article L5423-8 of the French Public Health Code
The following constitutes a breach subject to a financial penalty: 1° (Repealed) 2° (Repealed) 3° Failure by a pharmaceutical company exploiting a medicinal product or product subject to the marketing authorisation provided for in article L. 5121-8 to communicate the date of marketing of the medicinal product or product to the Agence nationale de sécurité du médicament et des produits de santé; 4° Managing a company with at least one…